diagnosed astrazeneca started trial vaccine candidate azd1222 united states month plans enroll 30,000 adults 80 sites country efficacy trials united kingdom brazil south africa involving total 17,000 people way double blind trial roughly 20,000 trial participants given doses vaccine 10,000 receive placebo large scale testing people needed regulators food drug administration approve vaccine widespread use countries including united states pre ordered millions doses oxford vaccine hope successful late month coronavirus vaccine candidate doses bought united kingdom european nations japan united states biomedical advanced research development authority given astrazeneca $ 1 billion develop oxford vaccine adverse events not uncommon clinical trials